In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: a systematic review
AH da Silva Hellwig, D Heidrich, RA Zanette… - Journal of global …, 2019 - Elsevier
Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …
In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review.
AH da Silva Hellwig, D Heidrich… - Journal of Global …, 2018 - europepmc.org
Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …
In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review
AH da Silva Hellwig, D Heidrich… - Journal of global …, 2019 - pubmed.ncbi.nlm.nih.gov
Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …